Metabolic fate of mescaline in man.

Suppr

超能文献

作者信息

Charalampous K D, Walker K E, Kinross-Wright J

出版信息

Psychopharmacologia. 1966;9(1):48-63. doi: 10.1007/BF00427703.

DOI:10.1007/BF00427703

PMID:5989103

Abstract

摘要

相似文献

Metabolic fate of mescaline in man.

Psychopharmacologia. 1966;9(1):48-63. doi: 10.1007/BF00427703.

Metabolic fate of beta-(3,4-dimethoxyphenyl)-ethylamine in man.

J Pharmacol Exp Ther. 1967 Feb;155(2):318-29.

Effects of chlorpromazine and haloperidol on the disposition of mescaline-14C in mice.

J Pharmacol Exp Ther. 1973 Aug;186(2):297-304.

Study with mescaline-8-C14 in mice: effect of amine oxidase inhibitors on metabolism.

Neuropharmacology. 1971 Sep;10(5):547-56. doi: 10.1016/0028-3908(71)90020-7.

Comparison of metabolism of mescaline and 3,4-dimethoxyphenylethylamine in humans.

Behav Neuropsychiatry. 1971 Feb-Mar;2(11):26-9 passim.

The metabolism of mescaline-14-C in rats.

Biochem Pharmacol. 1967 Jun;16(6):963-70. doi: 10.1016/0006-2952(67)90268-7.

METABOLIC FATE OF BETA-(3,4,5-TRIMETHOXYPHENYL)-ETHYLAMINE (MESCALINE) IN HUMANS: ISOLATION AND IDENTIFICATION OF 3,4,5-TRIMETHOXYPHENYLACETIC ACID.

J Pharmacol Exp Ther. 1964 Aug;145:242-6.

[Oxidative degradation of mescaline in the central nervous system. I. Properties of the mescaline-degrading enzyme].

Hoppe Seylers Z Physiol Chem. 1965;341(1):105-10.

A comparative study on the metabolism of 3,4-dimethoxyphenylethylamine-C 14 and mescaline-C 14 by rabbit, mouse and rat brain homogenates.

Arch Int Pharmacodyn Ther. 1971 Oct;193(2):357-61.

Placental transfer and tissue distribution of mescaline- 14 C in the mouse.

J Pharmacol Exp Ther. 1973 Feb;184(2):489-93.

引用本文的文献

Pharmacokinetics, Pharmacodynamics, and Urinary Recovery of Oral Mescaline Hydrochloride in Healthy Participants.

Clin Pharmacokinet. 2025 Jul 14. doi: 10.1007/s40262-025-01544-x.

Metabolism study of two phenethylamine - derived new psychoactive substances using in silico, in vivo, and in vitro approaches.

Arch Toxicol. 2025 Mar 10. doi: 10.1007/s00204-025-04010-6.

Acute dose-dependent effects of mescaline in a double-blind placebo-controlled study in healthy subjects.

Transl Psychiatry. 2024 Sep 30;14(1):395. doi: 10.1038/s41398-024-03116-2.

An Overview on the Hallucinogenic Peyote and Its Alkaloid Mescaline: The Importance of Context, Ceremony and Culture.

Molecules. 2023 Dec 5;28(24):7942. doi: 10.3390/molecules28247942.

Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants.

Neuropsychopharmacology. 2023 Oct;48(11):1659-1667. doi: 10.1038/s41386-023-01607-2. Epub 2023 May 25.

The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive Disorder.

Can J Psychiatry. 2023 Jan;68(1):5-21. doi: 10.1177/07067437221111371. Epub 2022 Aug 17.

Pharmacokinetic and Pharmacodynamic Aspects of Peyote and Mescaline: Clinical and Forensic Repercussions.

Curr Mol Pharmacol. 2019;12(3):184-194. doi: 10.2174/1874467211666181010154139.

Correlating the metabolic stability of psychedelic 5-HT₂A agonists with anecdotal reports of human oral bioavailability.

Neurochem Res. 2014 Oct;39(10):2018-23. doi: 10.1007/s11064-014-1253-y. Epub 2014 Feb 12.

Regional localization of [(14)C]mescaline in rabbit brain after intraventricular administration : Effects of chlorpromazine and iproniazid pretreatment.

Neurochem Res. 1977 Jun;2(3):265-79. doi: 10.1007/BF00969357.

Novel, unifying mechanism for mescaline in the central nervous system: electrochemistry, catechol redox metabolite, receptor, cell signaling and structure activity relationships.

Oxid Med Cell Longev. 2009 Sep-Oct;2(4):181-90. doi: 10.4161/oxim.2.4.9380.

本文引用的文献

The metabolism of mescaline with a note on correlations between metabolism and psychological effects.

J Nerv Ment Dis. 1959 Aug;129:177-83. doi: 10.1097/00005053-195908000-00007.

BIOCHEMICAL ASPECTS OF THE ACTIONS OF PSYCHOTOMIMETIC DRUGS.

Pharmacol Rev. 1965 Mar;17:1-25.

METABOLIC FATE OF BETA-(3,4,5-TRIMETHOXYPHENYL)-ETHYLAMINE (MESCALINE) IN HUMANS: ISOLATION AND IDENTIFICATION OF 3,4,5-TRIMETHOXYPHENYLACETIC ACID.

J Pharmacol Exp Ther. 1964 Aug;145:242-6.

DISTRIBUTION AND METABOLISM OF MESCALINE-C14 IN THE CAT BRAIN.

J Pharmacol Exp Ther. 1964 Apr;144:1-7.

HALLUCINOGENS. TOOLS FOR RESEARCH OR THERAPEUTIC AGENTS.

Tex State J Med. 1963 Sep;59:848-52.

The exzymic acetylation of serotonin and other naturally occurring amines.

Biochim Biophys Acta. 1961 Nov 25;54:190-2. doi: 10.1016/0006-3002(61)90954-4.

The clinical pharmacology of the hallucinogens.

Clin Pharmacol Ther. 1963 Jul-Aug;4:480-503. doi: 10.1002/cpt196344480.

Formation and metabolism of N-acetylnormetanephrine in the rat.

Biochim Biophys Acta. 1962 Jul 2;60:420-2. doi: 10.1016/0006-3002(62)90422-5.

Determination of liquid scientillation counting efficiency by pulse height shift.

Int J Appl Radiat Isot. 1960 May;8:1-7. doi: 10.1016/0020-708x(60)90153-8.

Pharmacology and metabolism of mescaline.

Rev Can Biol. 1958 Sep;17(3):389-409.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验